• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

魏斯评分与超越:肾上腺皮质癌的组织病理学。

The Weiss score and beyond--histopathology for adrenocortical carcinoma.

机构信息

Department of Clinical and Biological Sciences, University of Turin at San Luigi Hospital, regione Gonzole 10, 10043, Orbassano, Turin, Italy.

出版信息

Horm Cancer. 2011 Dec;2(6):333-40. doi: 10.1007/s12672-011-0088-0.

DOI:10.1007/s12672-011-0088-0
PMID:21997290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10358021/
Abstract

The pathological diagnosis of adrenocortical carcinoma (ACC) is still challenging for its rarity and the presence of special variants (pediatric, oncocytic, myxoid, and sarcomatoid). It is based on the recognition at light microscopy of at least three among nine morphological parameters, according to the Weiss scoring system, which has been introduced 27 years ago and nowadays is the most widely employed. Nevertheless, the diagnostic performance of this system is very high but does not reach a sensitivity and specificity of 100%, its diagnostic applicability is potentially low among non-expert pathologists, and a group of borderline cases with only one or two criteria exist of uncertain behavior. Moreover, it is scarcely reproducible in the ACC morphological variants. In fact, specifically for the pure oncocytic neoplasms that seem to have a better prognosis in comparison to the conventional ACCs, a modified system (the Lin-Weiss-Bisceglia) has been proposed. With the aim to simplify the ACC diagnosis, 2 years ago, the "reticulin" diagnostic algorithm has been proposed, based on the observation that the tumoral reticulin framework (highlighted by reticulin silver-based histochemical staining) is consistently disrupted in malignant cases but only in a small subset of benign cases. Following this algorithm, in the presence of reticulin alterations, malignancy is further defined through the identification of at least one of the following parameters: necrosis, high mitotic rate, and venous invasion. As a complement to the morphological approach, some immunohistochemical markers (such as steroidogenic factor 1) have been proposed as diagnostic and prognostic adjuncts but still lack wide clinical validation.

摘要

肾上腺皮质癌(ACC)的病理诊断仍然具有挑战性,因为其罕见且存在特殊变异型(儿童型、嗜酸细胞瘤型、黏液样型和肉瘤样型)。根据 Weiss 评分系统,该诊断基于在光镜下识别至少九个形态学参数中的三个,该系统于 27 年前引入,目前应用最广泛。然而,该系统的诊断性能虽然非常高,但无法达到 100%的敏感性和特异性,在非专家病理学家中其诊断适用性可能较低,并且存在一组仅有一个或两个标准的边界病例,其行为不确定。此外,该系统在 ACC 的形态变异型中几乎无法重现。事实上,特别是对于单纯嗜酸细胞瘤型肿瘤,与传统的 ACC 相比,其预后似乎更好,因此提出了一种改良的系统(Lin-Weiss-Bisceglia 系统)。为了简化 ACC 的诊断,两年前,提出了“网状纤维”诊断算法,该算法基于观察到肿瘤网状纤维框架(通过网状纤维银染色组织化学染色突出显示)在恶性病例中始终被破坏,但仅在一小部分良性病例中被破坏。根据该算法,在存在网状纤维改变的情况下,通过确定以下至少一个参数来进一步定义恶性肿瘤:坏死、高有丝分裂率和静脉侵犯。作为形态学方法的补充,一些免疫组织化学标志物(如类固醇生成因子 1)已被提议作为诊断和预后的辅助手段,但仍缺乏广泛的临床验证。

相似文献

1
The Weiss score and beyond--histopathology for adrenocortical carcinoma.魏斯评分与超越:肾上腺皮质癌的组织病理学。
Horm Cancer. 2011 Dec;2(6):333-40. doi: 10.1007/s12672-011-0088-0.
2
Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining.通过病理特征、免疫组织化学标志物和网状组织化学染色对肾上腺皮质癌进行诊断和预后评估。
Diagn Pathol. 2024 May 27;19(1):71. doi: 10.1186/s13000-024-01496-z.
3
Oncocytic adrenocortical tumors: diagnostic algorithm and mitochondrial DNA profile in 27 cases.嗜酸细胞瘤性肾上腺皮质肿瘤:27 例诊断算法和线粒体 DNA 谱分析。
Am J Surg Pathol. 2011 Dec;35(12):1882-93. doi: 10.1097/PAS.0b013e31822da401.
4
Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.《2022 年世界卫生组织肾上腺皮质肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):155-196. doi: 10.1007/s12022-022-09710-8. Epub 2022 Mar 14.
5
The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases.促纤维增生性肾上腺皮质肿瘤诊断的网状纤维算法:245 例未发表病例的多中心验证研究。
Am J Surg Pathol. 2013 Sep;37(9):1433-40. doi: 10.1097/PAS.0b013e31828d387b.
6
Pediatric Adrenocortical Neoplasms: A Study Comparing Three Histopathological Scoring Systems.小儿肾上腺皮质肿瘤:三种组织病理学评分系统比较的研究。
Endocr Pathol. 2023 Jun;34(2):213-223. doi: 10.1007/s12022-023-09767-z. Epub 2023 May 9.
7
Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center.肾上腺皮质癌的黏液样和肉瘤样变体:单三级医疗中心罕见变体分析
J Korean Med Sci. 2017 May;32(5):764-771. doi: 10.3346/jkms.2017.32.5.764.
8
Diagnosis of Adrenocortical Tumors by Reticulin Algorithm.通过网状纤维算法诊断肾上腺皮质肿瘤
Indian J Endocrinol Metab. 2017 Sep-Oct;21(5):734-737. doi: 10.4103/ijem.IJEM_573_16.
9
Adrenocortical oncocytic tumors: report of 10 cases and review of the literature.肾上腺皮质嗜酸性细胞瘤:10例报告并文献复习
Int J Surg Pathol. 2004 Jul;12(3):231-43. doi: 10.1177/106689690401200304.
10
Pathological and molecular features of adrenocortical carcinoma: an update.肾上腺皮质癌的病理和分子特征:最新进展。
J Clin Pathol. 2008 Jul;61(7):787-93. doi: 10.1136/jcp.2007.050625. Epub 2008 Apr 22.

引用本文的文献

1
A rare manifestation of adrenocortical carcinoma as a mimic of pheochromocytoma: a case report and literature review.肾上腺皮质癌罕见表现为酷似嗜铬细胞瘤:一例报告及文献复习
Front Endocrinol (Lausanne). 2025 Feb 11;16:1533711. doi: 10.3389/fendo.2025.1533711. eCollection 2025.
2
Adrenal oncocytoma: a rare presentation of a benign 18 F-fluorodeoxyglucose PET avid virilising adrenal tumour.肾上腺嗜酸性细胞瘤:一种罕见的表现为18F-氟脱氧葡萄糖PET摄取阳性的良性男性化肾上腺肿瘤。
Nucl Med Commun. 2025 Apr 1;46(4):367-372. doi: 10.1097/MNM.0000000000001932. Epub 2024 Nov 28.
3
Updates on WHO 5th edition classification, molecular characteristics and tumor microenvironment of adrenocortical carcinomas.肾上腺皮质癌的世界卫生组织第5版分类、分子特征及肿瘤微环境的最新进展
Endocr J. 2025 Mar 3;72(3):243-257. doi: 10.1507/endocrj.EJ24-0466. Epub 2024 Nov 12.
4
Adrenocortical Carcinomas: Molecular Pathogenesis, Treatment Options, and Emerging Immunotherapy and Targeted Therapy Approaches.肾上腺皮质癌:分子发病机制、治疗选择以及新兴的免疫治疗和靶向治疗方法。
Oncologist. 2024 Sep 6;29(9):738-746. doi: 10.1093/oncolo/oyae029.
5
Diagnostic Utility of a Modified Reticulin Algorithm in Pediatric Adrenocortical Neoplasms.改良网状纤维算法在儿科肾上腺皮质肿瘤中的诊断效用。
Am J Surg Pathol. 2024 Mar 1;48(3):309-316. doi: 10.1097/PAS.0000000000002174. Epub 2023 Dec 29.
6
Review of Diagnostic Modalities for Adrenal Incidentaloma.肾上腺偶发瘤的诊断方法综述
J Clin Med. 2023 May 29;12(11):3739. doi: 10.3390/jcm12113739.
7
A rare case of co-secreting adrenocortical oncocytoma.一例罕见的同时分泌型肾上腺皮质嗜酸性细胞瘤。
Urol Case Rep. 2022 Nov 25;46:102285. doi: 10.1016/j.eucr.2022.102285. eCollection 2023 Jan.
8
Corticomedullary Mixed Tumor of the Adrenal Gland with Apparent F-Fluorodeoxyglucose Activity But No GA-DOTATATE Uptake on Positron Emission Tomography/Computed Tomography.肾上腺皮质髓质混合瘤,在正电子发射断层扫描/计算机断层扫描上表现出明显的F-氟脱氧葡萄糖活性,但无镓-多柔比星摄取。
Indian J Nucl Med. 2022 Jul-Sep;37(3):297-298. doi: 10.4103/ijnm.ijnm_194_21. Epub 2022 Nov 2.
9
Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases.这是肾上腺皮质腺瘤还是肾上腺皮质癌?Weiss评分系统在确定肾上腺皮质肿瘤恶性潜能方面的局限性:两例报告
Case Rep Endocrinol. 2022 Sep 14;2022:7395050. doi: 10.1155/2022/7395050. eCollection 2022.
10
Is the Adrenal Incidentaloma Functionally Active? An Approach-To-The-Patient-Based Review.肾上腺偶发瘤是否具有功能活性?基于患者的评估方法综述。
J Clin Med. 2022 Jul 14;11(14):4064. doi: 10.3390/jcm11144064.

本文引用的文献

1
Adrenocortical carcinoma: a clinician's update.肾上腺皮质癌:临床医生的最新进展。
Nat Rev Endocrinol. 2011 Jun;7(6):323-35. doi: 10.1038/nrendo.2010.235. Epub 2011 Mar 8.
2
The argument for mitotic rate-based grading for the prognostication of adrenocortical carcinoma.基于有丝分裂率的分级对肾上腺皮质癌预后评估的论据。
Am J Surg Pathol. 2011 Apr;35(4):471-3. doi: 10.1097/PAS.0b013e31820bcf21.
3
Oncocytic adrenocortical neoplasms--a clinicopathologic study of 13 new cases emphasizing the importance of their recognition.嗜酸细胞瘤性肾上腺皮质肿瘤——13 例新病例的临床病理研究,强调其识别的重要性。
Hum Pathol. 2011 Apr;42(4):489-99. doi: 10.1016/j.humpath.2010.08.010. Epub 2011 Jan 14.
4
Classification of adrenal cortical tumors: what limits for the pathological approach?肾上腺皮质肿瘤分类:病理方法的局限性有哪些?
Best Pract Res Clin Endocrinol Metab. 2010 Dec;24(6):877-85. doi: 10.1016/j.beem.2010.10.011.
5
Genetics and genomics of childhood adrenocortical tumors.儿童肾上腺皮质肿瘤的遗传学和基因组学。
Mol Cell Endocrinol. 2011 Apr 10;336(1-2):169-73. doi: 10.1016/j.mce.2010.11.008. Epub 2010 Nov 19.
6
β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma.β-连环蛋白的激活与肾上腺皮质癌的特定临床和病理特征以及不良预后相关。
Clin Cancer Res. 2011 Jan 15;17(2):328-36. doi: 10.1158/1078-0432.CCR-10-2006. Epub 2010 Nov 18.
7
Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers.转录组分析显示,一组侵袭性肾上腺皮质癌中存在 p53 和 {β}-连环蛋白的改变。
Cancer Res. 2010 Nov 1;70(21):8276-81. doi: 10.1158/0008-5472.CAN-10-2014. Epub 2010 Oct 19.
8
Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade.建议使用肿瘤分级修改肾上腺皮质癌的 ENSAT 分期系统。
Langenbecks Arch Surg. 2010 Sep;395(7):955-61. doi: 10.1007/s00423-010-0698-y. Epub 2010 Aug 9.
9
Adrenocortical carcinosarcoma: a case report and review of the literature.肾上腺皮质癌肉瘤:病例报告及文献复习。
Diagn Pathol. 2010 Aug 5;5:51. doi: 10.1186/1746-1596-5-51.
10
High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.类固醇生成因子-1 在肾上腺肿瘤中的诊断和预后价值很高。
J Clin Endocrinol Metab. 2010 Oct;95(10):E161-71. doi: 10.1210/jc.2010-0653. Epub 2010 Jul 21.